JP2005519057A5 - - Google Patents

Download PDF

Info

Publication number
JP2005519057A5
JP2005519057A5 JP2003557585A JP2003557585A JP2005519057A5 JP 2005519057 A5 JP2005519057 A5 JP 2005519057A5 JP 2003557585 A JP2003557585 A JP 2003557585A JP 2003557585 A JP2003557585 A JP 2003557585A JP 2005519057 A5 JP2005519057 A5 JP 2005519057A5
Authority
JP
Japan
Prior art keywords
linker
active ingredient
therapeutic agent
quaternary ammonium
infectious diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003557585A
Other languages
English (en)
Japanese (ja)
Other versions
JP4452777B2 (ja
JP2005519057A (ja
Filing date
Publication date
Priority claimed from DE10200717A external-priority patent/DE10200717A1/de
Application filed filed Critical
Publication of JP2005519057A publication Critical patent/JP2005519057A/ja
Publication of JP2005519057A5 publication Critical patent/JP2005519057A5/ja
Application granted granted Critical
Publication of JP4452777B2 publication Critical patent/JP4452777B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003557585A 2002-01-10 2003-01-10 抗−感染物質としての多糖誘導体の使用 Expired - Fee Related JP4452777B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10200717A DE10200717A1 (de) 2002-01-10 2002-01-10 Verwendung von Polysaccharid-Derivaten als antiinfektive Substanzen
PCT/DE2003/000095 WO2003057227A1 (de) 2002-01-10 2003-01-10 Verwendung von polysaccharid-derivaten als antiinfektive substanzen

Publications (3)

Publication Number Publication Date
JP2005519057A JP2005519057A (ja) 2005-06-30
JP2005519057A5 true JP2005519057A5 (enExample) 2006-03-02
JP4452777B2 JP4452777B2 (ja) 2010-04-21

Family

ID=7711838

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003557585A Expired - Fee Related JP4452777B2 (ja) 2002-01-10 2003-01-10 抗−感染物質としての多糖誘導体の使用

Country Status (17)

Country Link
US (1) US7297687B2 (enExample)
EP (1) EP1465640B8 (enExample)
JP (1) JP4452777B2 (enExample)
KR (1) KR100913301B1 (enExample)
CN (1) CN1615141B (enExample)
AT (1) ATE408411T1 (enExample)
AU (1) AU2003210125B2 (enExample)
BR (1) BRPI0306851A8 (enExample)
CA (1) CA2472586C (enExample)
DE (2) DE10200717A1 (enExample)
ES (1) ES2314205T3 (enExample)
MX (1) MXPA04006673A (enExample)
NO (1) NO20043265L (enExample)
PL (1) PL206600B1 (enExample)
RU (1) RU2332221C2 (enExample)
WO (1) WO2003057227A1 (enExample)
ZA (1) ZA200405400B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060163149A1 (en) * 2003-06-13 2006-07-27 Torkel Wadstrom Product for absorption purposes
CN100469707C (zh) * 2005-03-11 2009-03-18 中国石化北京燕化石油化工股份有限公司 一种高浊高铁循环冷却水的处理方法
KR101278106B1 (ko) * 2011-03-03 2013-06-24 이원실 이온성 액체를 이용한 셀룰로오스계 고분자 항균제의 제조방법
WO2013132061A1 (de) 2012-03-09 2013-09-12 Friedrich-Schiller-Universität Jena Di- und multifunktional amin-modifizierte oligo- und polysaccharidderivate als antiinfektive substanzen und deren verwendung
WO2016088124A1 (en) * 2014-12-02 2016-06-09 B. G. Negev Technologies And Applications Ltd., At Ben-Gurion University Modified polysaccharides for use as anti-microbial agents
FR3064473B1 (fr) * 2017-04-03 2021-02-12 Basf Beauty Care Solutions France Sas Ingredient protecteur de l'equilibre de la flore microbienne cutanee et/ou mucosale
CN112423771B (zh) * 2018-07-20 2023-05-09 株式会社资生堂 病毒灭活剂
CN115260320B (zh) * 2021-04-30 2023-05-05 中国科学院化学研究所 离子型多糖衍生物用作防冰涂层材料的应用
KR102559540B1 (ko) 2022-09-19 2023-07-25 문건희 토류벽시스템용 토류벽체

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60203265A (ja) * 1984-03-28 1985-10-14 ダイセル化学工業株式会社 抗血液凝固性高分子材料
DE3711680A1 (de) * 1987-04-07 1988-10-27 Hoechst Ag Waessrige biozide kationische kunststoffdispersionen und deren verwendung als fungizide, bakterizide und algizide ausruestungsmittel
DE3720555A1 (de) * 1987-06-22 1989-01-05 Henkel Kgaa Verwendung von unloeslichen, polyfunktionellen quartaeren ammoniumverbindungen zur adsorptiven bindung von mikroorganismen
IT1231168B (it) * 1989-07-21 1991-11-22 Texcontor Ets Copolimeri saccaridici aventi attivita' antibatterica.
JPH0457969A (ja) * 1990-06-27 1992-02-25 Unitika Ltd 抗菌性布帛の製造方法
US5731259A (en) * 1991-05-03 1998-03-24 Societa Consortile Ricerche Angelini S.P.A. Cationic polysaccharides
IT1249309B (it) * 1991-05-03 1995-02-22 Faricerca Spa Polisaccaridi di tipo cationico
GB2262531B (en) * 1991-12-17 1995-12-06 Erba Carlo Spa Antiviral sulphated polysaccharides
JPH05295002A (ja) * 1992-04-23 1993-11-09 Nichiden Kagaku Kk 抗菌性澱粉、水溶性多糖類及びその製造方法
ZA947572B (en) * 1993-09-29 1995-09-28 Hampton Roads Medical College Contraceptive compositions
RU2098114C1 (ru) * 1995-02-03 1997-12-10 Музыка Владислав Иванович Препарат, воздействующий на функциональную активность клеток эукариот и прокариот
JPH10155898A (ja) * 1996-11-26 1998-06-16 Toyobo Co Ltd 抗菌性付与抗血栓性材料
US6096291A (en) 1996-12-27 2000-08-01 Biovector Therapeutics, S.A. Mucosal administration of substances to mammals
US6306835B1 (en) * 1997-09-23 2001-10-23 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Biocidal chitosan derivatives
JP3961714B2 (ja) * 1998-04-09 2007-08-22 ナショナル スターチ アンド ケミカル インベストメント ホールディング コーポレイション 毛髪化粧用組成物
AU6473499A (en) 1998-10-29 2000-05-22 Ciba Specialty Chemicals Holding Inc. Incorporation of organic anti-microbials into fibres during a fibre spinning process

Similar Documents

Publication Publication Date Title
JP2006526031A5 (enExample)
JP2008506632A5 (enExample)
JP2007051159A5 (enExample)
EA200800657A1 (ru) Способ приготовления очищенных конъюгатов лекарственных средств
NO2017005I1 (no) Human pappilomavirus vaksine [type 6, 11, 16, 18, 31, 33, 45, 52, 58]
JP2003503454A5 (enExample)
NO20071667L (no) Farmasoytisk preparat omfattende levetiracetam og fremgangsmate for fremstilling av preparatet
CY1111934T1 (el) Σταθεροποιημενες φαρμακευτικες συνθεσεις οι οποιες περιεχουν φεσοτεροδινη
JP2007302683A5 (enExample)
JP2007522094A5 (enExample)
BRPI0412851A (pt) benzamidazóis de n-metila-substituìdos
JP2007520565A5 (enExample)
JP2005519057A5 (enExample)
DK1932522T3 (da) Terapeutisk middel mod leversygdom indeholdende 2-amino-1,3-propandiolderivat som aktiv bestanddel
WO2007009721A3 (en) Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments
RU2008147216A (ru) Жидкая лекарственная композиция
WO2007098967A3 (en) Imidazole compounds having pharmaceutical activity towards the sigma receptor
JP2006525972A5 (enExample)
MX2009005912A (es) Derivados de etilamina-fenilo heterociclilo sustituidos, su preparacion y uso como medicamentos.
WO2007009686A3 (en) Substituted pyrazoline compounds, their preparation and use as medicaments
JP2006342148A5 (enExample)
RU2003110288A (ru) Вещество, обладающее антидепрессивной активностью
WO2009054150A1 (ja) テトラピロール誘導体およびその医薬用途
Kolata For a world of woes, we blame cookie monsters
Koyanagi Small animal model for HIV-1 Disease